Multi-modal Magnetic Resonance Imaging (MRI) provide sufficient complementary information for brain tumor segmentation, however, most current approaches rely on complete modalities and may collapse with incomplete modalities. Moreover, most existing endeavors focus on training with centralized databases, failing to make full use of distributed multi-silo datasets with rich patient data to learn a more robust brain tumor segmentation model. In this paper, considering the distributed training scenarios, we formulate Federated Incomplete Multi-modal Learning (FedIML) for brain tumor segmentation, and propose Progressive distiLlation with Optimal Transport (PLOT) framework to gradually train a modality robust segmentation model at each client and achieve compatible model aggregation at the server. Specifically, to remedy the issue of unstable local training caused by the random modality input, we present Modality Progressive Distillation (MPD), a multi-level knowledge distillation strategy guided by a modality routing mechanism. At each client, MPD provides a gradually learning course for a student model in an easy-to-hard manner to achieve a stable local training process. Moreover, to address the problem that the layer-wise knowledge from different models may contradict, at the server, we design Optimal Transport-guided Model Aggregation (OTMA) strategy, which yields a global alignment solution for model parameters via solving an optimal transport problem. OTMA can achieve a compatible parameter aggregation and boost the distributed training. Extensive experiments on the BraTS-2021 dataset demonstrate the effectiveness of the proposed framework over state-of-the-art methods.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/JBHI.2025.3525854 | DOI Listing |
Ann Med
December 2025
Department of Assisted Reproductive Centre, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, China.
Background: Butyrate may inhibit SARS-CoV-2 replication and affect the development of COVID-19. However, there have been no systematic comprehensive analyses of the role of butyrate metabolism-related genes (BMRGs) in COVID-19.
Methods: We performed differential expression analysis of BMRGs in the brain, liver and pancreas of COVID-19 patients and controls in GSE157852 and GSE151803.
Handb Clin Neurol
March 2025
Donders Institute for Brain Cognition Behaviour, Radboud University, Nijmegen, The Netherlands; Brain Connectivity and Behaviour Laboratory, Sorbonne Universities, Paris, France; Centre for Neuroimaging Sciences, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Brain tumors are classified as rare diseases, with an annual occurrence of 300,000 cases and account for an annual loss of 241,000 lives, highlighting their devastating nature. Recent advancements in diagnosis and treatment have significantly improved the management and care of brain tumors. This chapter provides an overview of the common types of primary brain tumors affecting language functions-gliomas and meningiomas.
View Article and Find Full Text PDFJ Vet Med Sci
March 2025
Laboratory of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo.
A 5-year-4-month-old neutered female French bulldog had a brain mass that was surgically excised. Histologically, the tumor consisted of neoplastic oligodendroglial and spindle-shaped cells, and chondroid tissues. Immunohistochemically, oligodendroglial cells were immunopositive for oligodendrocyte transcription factor 2 (OLIG2), 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase), platelet-derived growth factor receptor alpha (PDGFRA), vimentin, cluster of differentiation 44 (CD44), and WW domain containing transcription regulator 1 (WWTR1).
View Article and Find Full Text PDFJ Control Release
March 2025
Clinical Biochemistry, Drug Delivery and Therapy Group (CB-DDT), Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035 Barcelona, Spain; Functional Validation & Preclinical Research (FVPR)/U20 ICTS Nanbiosis, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona (UAB), 08035 Barcelona, Spain; Department of Pharmacy and Pharmaceutical Technology and Physicochemistry, Faculty of Pharmacy and Food Sciences, School of Pharmacy, Universitat de Barcelona (UB), Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain. Electronic address:
Glioblastoma multiforme (GBM) is one of the most lethal cancers, with limited treatment options due to the blood-brain barrier (BBB), systemic toxicity, and treatment resistance. Nanomedicine offers potential solutions to these challenges. This study explores Pluronic® F127 and Soluplus®-based micelles as carriers for Lomustine, Gefitinib, and Docetaxel to determine the optimal system for GBM therapy.
View Article and Find Full Text PDFIt is known that inhibition of the endoplasmic reticulum transmembrane signaling protein (ERN1) suppresses the glioblastoma cells proliferation. The present study aims to investigate the impact of inhibition of ERN1 endoribonuclease and protein kinase activities on the , , and gene expression in U87MG glioblastoma cells with an intent to reveal the role of ERN1 signaling in the regulation of expression of these genes. The U87MG glioblastoma cells with inhibited ERN1 endoribonuclease (dnrERN1) or both enzymatic activities of ERN1 (endoribonuclease and protein kinase; dnERN1) were used.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!